Form 4 for IDXX Idexx Laboratories
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001567619-21-020098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-12 | 2021-11-10 | IDXX | MCKEON BRIAN P | CFO, Executive VP | S - Sale+OE | $624.96 | -20.0K | 37.8K | -35% | -$12.50M |
| D | 2021-11-12 | 2021-11-10 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | $67.85 | +20.0K | 46.3K | +76% | +$1.36M |
| D | 2021-11-12 | 2021-11-10 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | — | -20.0K | 9,225 | -68% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | S | D | 1,262 | $621.40 | 45,054.64 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $620.78 to $621.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-10 | S | D | 1,375 | $628.78 | 27,188.64 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $628.34.10 to $629.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-10 | S | D | 2,974 | $627.97 | 28,563.64 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $627.32 to $628.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2021-11-10 | S | D | 1,813 | $626.74 | 31,537.64 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $626.10 to $627.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-11-10 | S | D | 2,326 | $625.46 | 33,350.64 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $625.06 to $626.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2021-11-10 | S | D | 2,142 | $624.53 | 35,676.64 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $624.04 to $625.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2021-11-10 | M | A | 20,000 | $67.85 | 46,316.64 | D | — | — | |
| 8 | Common | Common Stock | 2021-11-10 | S | D | 872 | $629.80 | 26,316.64 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $629.46 to $630.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2021-11-10 | S | D | 5,743 | $622.36 | 39,311.64 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $621.79 to $622.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2021-11-10 | S | D | 1,493 | $623.34 | 37,818.64 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $622.97 to $623.965. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-11-10 | M | D | 20,000 | — | 9,225 | D | $67.85 · — to 2026-02-13 | 20,000 Common Stock | (F11) Not applicable. (F10) Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017. |